The administration of high-mobility group box 1 fragment prevents deterioration of cardiac performance by enhancement of bone marrow mesenchymal stem cell homing in the delta-sarcoglycan-deficient hamster

OBJECTIVES: We hypothesized that systemic administration of high-mobility group box 1 fragment attenuates the progression of myocardial fibrosis and cardiac dysfunction in a hamster model of dilated cardiomyopathy by recruiting bone marrow mesenchymal stem cells thus causing enhancement of a self-re...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:PLoS One
Auteurs principaux: Kido, Takashi, Miyagawa, Shigeru, Goto, Takasumi, Tamai, Katsuto, Ueno, Takayoshi, Toda, Koichi, Kuratani, Toru, Sawa, Yoshiki
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2018
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6281303/
https://ncbi.nlm.nih.gov/pubmed/30517097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0202838
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires